Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04597086 · ClinicalTrials.gov registry record · NA
Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT04597086 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 74 participants.
The verdict
NCT04597086, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
This trial investigates how well bright white light therapy works in improving sleep, fatigue, distress, depression, and anxiety, side effects that are often experienced during an intense leukemia treatment regimen, in hospitalized leukemia patients. Bright white light therapy may help to control these symptoms, and information from this study may help doctors and nurses learn more about methods for decreasing these symptoms.
Interventions
- OTHER Survey Administration
- OTHER Best Practice
- PROCEDURE Bright White Light Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2020-09-14 |
| Est. Completion | 2023-01-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04597086
The ClinicalTrials.gov registry entry for NCT04597086 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.
NCT04597086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04597086 about?
NCT04597086 is a clinical study titled "Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients". This trial investigates how well bright white light therapy works in improving sleep, fatigue, distress, depression, and anxiety, side effects that are often experienced during an intense leukemia treatment regimen, in hospitalized leukemia patients. Bright white light therapy may help to control th...
What is the current status of trial NCT04597086?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2020-09-14. Estimated completion is 2023-01-13.
What interventions are being tested in trial NCT04597086?
The interventions under investigation include: Survey Administration (OTHER), Best Practice (OTHER), Bright White Light Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT04597086?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.